1.
Indian Heart J
;
2008 Mar-Apr; 60(2): 149-51
Article
in English
| IMSEAR
| ID: sea-4731
ABSTRACT
Patients with multivessel disease and LV dysfunction are conventionally treated with coronary artery bypass surgery. With the advent of drug eluting stents, complex lesions are now being tackled percutaneously. The ARTS II registry demonstrated the efficacy and safety of sirolimus-eluting stents (SES) in patients with multivessel disease. We report a case of "complete revascularization" with 9 sirolimus-eluting stents in a patient with multivessel disease and LV dysfunction with an angiographic evaluation at 6 months and 1 year.
Subject(s)
Coronary Artery Disease/drug therapy , Drug-Eluting Stents , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Myocardial Revascularization , Sirolimus/therapeutic use , Ventricular Dysfunction, Left
2.
J Indian Med Assoc
;
1977 May; 68(9): 177-82
Article
in English
| IMSEAR
| ID: sea-100487